Partnering with CLS-Therapeutics

We believe that we can best achieve our goals together with partners who can supplement and complement our strengths and capabilities.

If you are interested in partnering with us in the development of CLS-014 (Deoxynucleogene Ancparvovec) please contact us at

CLS Therapeutics has partnered with leading medical and research organizations to advance CLS-014.